Pro Health Tips
Friday, 19 February 2021
FDA Approves Drug To Protect Against Chemo-Induced Myelosuppression
US FDA approved trilaciclib to offer protection against chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer (ES-SCLC).
from Medindia Health News https://ift.tt/2ZyyX4e
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
US FDA approved trilaciclib to offer protection against chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer (ES-SCLC).
No comments:
Post a Comment